2025 JBJS EST Award Winners
OrthoBuzz is pleased to highlight the winners of the JBJS Essential Surgical Techniques (EST) Editor’s Choice Awards for 2025. Each …
Q&A with Jason Miller, JBJS Chief Executive Officer
This interview is part of the OrthoBuzz “Inside JBJS” series, where we take readers behind the scenes to meet members …
To Fix or Not to Fix? The Clavicle Fracture Debate Still Isn’t Settled
This guest post comes from Professor Tom Cosker, Consultant Orthopaedic Surgeon and Director of Surgical Anatomy and Associate Professor at …
Navigating the Business of Orthopaedic Surgery
This Editor’s Choice post is by Dr. Matt Schmitz, JBJS Senior Editor for Pediatrics and Social Media.
Do the omniscient …
What’s New in Musculoskeletal Infection 2026
The latest research in musculoskeletal infection is presented in the new JBJS Specialty Update What’s New in Musculoskeletal Infection. …
A Year in Review: The 2025-26 JBJS Robert Bucholz Resident Journal Club Support Program
Each year, the JBJS Robert Bucholz Resident Journal Club Support Program helps orthopaedic residency programs strengthen journal club activities, support …
Multicenter Randomized Trial Finds One-Stage Noninferior to Two-Stage Revision for Chronic PJI
OrthoBuzz spotlights a prospective, multicenter, randomized trial now in JBJS.
Periprosthetic joint infection (PJI) can severely impact a patient’s life …
What’s New in Orthopaedic Trauma 2026
New research in orthopaedic trauma is discussed in the latest JBJS Specialty Update, What’s New in Orthopaedic Trauma. Here, …
2025 Impact Factors Are In—JBJS Portfolio Shows Steady Growth and Strong Open-Access Momentum
JBJS is pleased to share this year’s Journal Impact Factor results for the JBJS portfolio, which showed steady progress overall …